Outcome of combined bevacizumab and irinotecan for patients with progressive brain metastases from non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Brosnan, Evelyn M.
Fadul, Camilo E.
Dragnev, Konstantin H.
Davis, Melissa C.
Shah, Khushboo A.
Eskey, Clifford J.
机构：
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[2] Dartmouth Hitchcock Medcl Ctr, Lebanon, NH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19059
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Treatment and outcome of patients with brain metastases from non-small cell lung cancer (NSCLC)
    Ali, A.
    Goffin, J. R.
    Arnold, A.
    Ellis, P. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] The impact of bevacizumab on the occurrence and recurrence of intracranial brain metastases in non-small cell lung cancer (NSCLC) patients
    Salem, Mohamed E.
    Szerlip, Nicholas
    Pennell, Nathan A.
    Ali, Khaled B.
    Altshuler, David
    Taylor, Stephanie
    Hallock, Abhirami
    Sukari, Ammar
    Gadgeel, Shirish M.
    Wozniak, Antoinette J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] SURVIVAL OF PATIENTS WITH BRAIN METASTASES AND NON-SMALL CELL LUNG CANCER (NSCLC)
    Randhawa, J. K.
    Patel, S. P.
    Stokes, T. C.
    THORAX, 2009, 64 : A148 - A148
  • [4] Outcome of whole brain radiotherapy (WBRT) in patients with inoperable brain metastases from non-small cell lung cancer (NSCLC)
    Namelo, W. C.
    Brewster, A. E.
    Thomas, M.
    LUNG CANCER, 2013, 79 : S56 - S56
  • [5] Safety of bevacizumab therapy in subjects with brain metastases due to non-small cell lung cancer (NSCLC)
    Akerley, Wallace
    Hainsworth, John
    Oh, Yun
    Strickland, Dk
    Royer-Joo, Stephanie
    Zhou, Xian
    Xia, Qi
    Huang, Jane
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S467 - S467
  • [6] Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases
    Mustafa S. Ascha
    Jacqueline Fang Wang
    Priya Kumthekar
    Andrew E. Sloan
    Carol Kruchko
    Jill S. Barnholtz-Sloan
    Scientific Reports, 9
  • [7] Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases
    Ascha, Mustafa S.
    Wang, Jacqueline Fang
    Kumthekar, Priya
    Sloan, Andrew E.
    Kruchko, Carol
    Barnholtz-Sloan, Jill S.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [8] Brain metastases in advanced non-small cell lung cancer post bevacizumab
    Huang Yujuan
    Yang Jinji
    Wang Zhen
    Huang Yisheng
    Wu Yilong
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S684 - S684
  • [9] Effect of erlotinib plus bevacizumab on brain metastases in patients with non-small cell lung cancer
    Chikaishi, Yasuhiro
    Kanayama, Masatoshi
    Taira, Akihiro
    Nabe, Yusuke
    Shinohara, Shinji
    Kuwata, Taiji
    Takenaka, Masaru
    Oka, Soichi
    Hirai, Ayako
    Kuroda, Koji
    Imanishi, Naoko
    Ichiki, Yoshinobu
    Tanaka, Fumihiro
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (20)
  • [10] THE ADMINISTRATION OF BEVACIZUMAB FOR NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS WITH BRAIN METASTASES
    Fukunaga, Kentaro
    Kawashima, Satoru
    Yoshihashi, Saiko
    Seto, Ruriko
    Kanda, Rie
    Higami, Yuichi
    Goto, Kenichi
    Ryujin, Yasushi
    Nakagawa, Hiroaki
    Van Tho, Nguyen
    Yamaguchi, Masafumi
    Oguma, Tetuya
    Nagao, Taishi
    Ogawa, Emiko
    Nakano, Yasutaka
    RESPIROLOGY, 2013, 18 : 87 - 87
12345